⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL156789 | 0.81 | TSHR (0.34) | — | |
| SCHEMBL1489814 | 0.79 | — | — | |
| SCHEMBL35770 | 0.77 | — | — | |
| SCHEMBL964294 | 0.77 | — | — | |
| SCHEMBL3778981 | 0.77 | — | — | |
| Acrylamide SCHEMBL5945502 | 0.77 | TSHR (0.48) | — | |
| SCHEMBL3478304 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL6416074 | 0.75 | TSHR (0.35) | — | |
| Ethylene SCHEMBL5586541 | 0.75 | TSHR (0.35) | — | |
| SCHEMBL15877804 | 0.75 | TSHR (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116209448-A | Cationic steroidal antimicrobial compounds and methods of making such compounds | 布莱阿姆青年大学 | 2023-06-02 | — | — | CN | claimed |
| CN-116209669-A | Cationic steroidal antimicrobial compounds with endogenous groups | 布莱阿姆青年大学 | 2023-06-02 | — | — | CN | claimed |
| US-20210238210-A1 | ANTIVIRAL COMPOUNDS | VIROVAX LLC | 2021-08-05 | — | — | US | claimed |
| EP-2963031-A2 | PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME | Zynerba Pharmaceuticals, Inc. (US) | 2016-01-06 | — | — | EP | claimed |
| US-8980942-B2 | Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same | ZYNERBA PHARMACEUTICALS, INC. (US) | 2015-03-17 | — | — | US | claimed |
| US-20120289484-A1 | PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME | ALLTRANZ INC. | 2012-11-15 | — | — | US | claimed |
| EP-2215071-A1 | PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME | AllTranz Inc. (US) | 2010-08-11 | — | — | EP | claimed |
| WO-2009073633-A1 | PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME | ALLTRANZ INC. (US) | 2009-06-11 | — | — | WO | claimed |
| US-20090143462-A1 | Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same | ALLTRANZ (US) | 2009-06-04 | — | — | US | claimed |
| US-12029708-B2 | Alkoxy compounds for disease treatment | ACUCELA INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240217942-A1 | PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME | ZYNERBA PHARMACEUTICALS, INC. (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-23 | — | — | US | disclosed |
| US-20240083866-A1 | PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME | ZYNERBA PHARMACEUTICALS, INC. (US) | 2024-03-14 | — | — | US | disclosed |
| US-11891457-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-02-06 | — | — | US | disclosed |
| WO-2000053653-A1 | POWDER SLURRY COMPOSITION CONTAINING PARTICULATE CARBAMATE FUNCTIONAL COMPOUNDS | BASF CORPORATION (US) | 2000-09-14 | — | — | WO | disclosed |
| WO-2000036028-A1 | PARTICULATE CARBAMATE FUNCTIONAL COMPOUNDS AND POWDER COATINGS COMPRISING THE SAME | BASF CORPORATION (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-0530252-A4 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | US HEALTH (US) | 1993-09-01 | — | — | EP | disclosed |
| EP-0530252-A1 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE (US) | 1993-03-10 | — | — | EP | disclosed |
| WO-1989005853-A1 | NUCLEIC ACID CHELATE CONJUGATE AS THERAPEUTIC AND DIAGNOSTIC AGENTS | SYNTHETIC GENETICS (US) | 1989-06-29 | — | — | WO | disclosed |
| US-4155869-A | Phosphate esters of oxyalkylated beta-amino lower-alkyl carbamates as scale inhibitors | STANDARD OIL COMPANY (INDIANA) (US) | 1979-05-22 | — | — | US | disclosed |